MECHANISMS OF INTESTINAL CELL MIGRATION
肠细胞迁移的机制
基本信息
- 批准号:6381820
- 负责人:
- 金额:$ 7.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-08-01 至 2003-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (adapted from the application)
Currently, the only available treatments for infants with infectious diarrhea
are oral rehydration and antibiotics. Previous work focused on amino acids,
specifically glutamine (GLN) and arginine (ARG), because of their cost, safety,
proabsorptive effect, and capacity to promote intestinal repair. Of the two
amino acids, ARG was found to be more effective in enhancing restitution, the
initial stage of intestinal repair during which the columnar cells migrate to
cover basement membrane. ARG synergized with fetal bovine serum or a bovine
serum concentrate to enhance migration of wounded intestinal epithelial
monolayers and to facilitate recovery of transepithelial electrical resistance
of acutely injured pig ileum. The aims of the current proposal are to study the
mechanisms of these complementary effects of ARG and serum. The central
hypothesis is that after injury serum (and bovine serum concentrate) provide
growth factors which synergize with arginine-derived nitric oxide and
polyamines to potentiate molecular signaling during migration and restitution.
Focal adhesions are multiprotein complexes in extending lamellipodia during
epithelial cell migration. Several kinases are activated by protein tyrosine
phosphorylation at focal adhesions during intestinal cell migration. We will
measure the expression and activity of focal adhesion kinase (FAK),
calcium-dependent tyrosine kinase (CADTK, also called PYK-2),
extracellular-related kinases (ERK's -1 and -2), and p70s6k during intestinal
cell migration, comparing cells and tissues treated with ARG + serum. Active
growth peptides in serum will be identified and quantified. We will determine
if ARG potentiates serum growth factor signaling or activates separate
signaling pathways during migration.
描述(改编自应用程序)
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JON Marc RHOADS其他文献
JON Marc RHOADS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JON Marc RHOADS', 18)}}的其他基金
Road to discovery for combination probiotic BB-12 with LGG in treating autism spectrum disorder
益生菌 BB-12 与 LGG 组合治疗自闭症谱系障碍的发现之路
- 批准号:
10657357 - 财政年份:2018
- 资助金额:
$ 7.28万 - 项目类别:
Road to discovery for combination probiotic BB-12 with LGG in treating autism spectrum disorder
益生菌 BB-12 与 LGG 组合治疗自闭症谱系障碍的发现之路
- 批准号:
9766942 - 财政年份:2018
- 资助金额:
$ 7.28万 - 项目类别:
Road to discovery for combination probiotic BB-12 with LGG in treating autism spectrum disorder
益生菌 BB-12 与 LGG 组合治疗自闭症谱系障碍的发现之路
- 批准号:
10439571 - 财政年份:2018
- 资助金额:
$ 7.28万 - 项目类别:
Road to discovery for combination probiotic BB-12 with LGG in treating autism spectrum disorder
益生菌 BB-12 与 LGG 组合治疗自闭症谱系障碍的发现之路
- 批准号:
9969235 - 财政年份:2018
- 资助金额:
$ 7.28万 - 项目类别:
Safety and Effect of L. reuteri on Biomarkers of Inflammation in Healthy Infants
罗伊氏乳杆菌的安全性及其对健康婴儿炎症生物标志物的影响
- 批准号:
8650793 - 财政年份:2012
- 资助金额:
$ 7.28万 - 项目类别:
Safety and Effect of L. reuteri on Biomarkers of Inflammation in Healthy Infants
罗伊氏乳杆菌的安全性及其对健康婴儿炎症生物标志物的影响
- 批准号:
8304030 - 财政年份:2012
- 资助金额:
$ 7.28万 - 项目类别:
Effect of Lactobactocillus Rhamnosus GG on Colic Symptoms and Breath Hydrogen
鼠李糖乳杆菌 GG 对绞痛症状和呼气氢的影响
- 批准号:
7314788 - 财政年份:2008
- 资助金额:
$ 7.28万 - 项目类别:
Phase I: Safety and Tolerance of Lactobactocillus reuteri in Adults
第一阶段:罗伊氏乳杆菌在成人中的安全性和耐受性
- 批准号:
7663878 - 财政年份:2008
- 资助金额:
$ 7.28万 - 项目类别:
Phase I: Safety and Tolerance of Lactobactocillus reuteri in Adults
第一阶段:罗伊氏乳杆菌在成人中的安全性和耐受性
- 批准号:
7920228 - 财政年份:2008
- 资助金额:
$ 7.28万 - 项目类别:
Phase I: Safety and Tolerance of Lactobactocillus reuteri in Adults
第一阶段:罗伊氏乳杆菌在成人中的安全性和耐受性
- 批准号:
8259339 - 财政年份:2008
- 资助金额:
$ 7.28万 - 项目类别:
相似海外基金
ROLE OF CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
细胞粘附在生物信号转导中的作用
- 批准号:
6238317 - 财政年份:1997
- 资助金额:
$ 7.28万 - 项目类别:
ROLE OF CELL ADHESION IN BIOLOGICAL SIGNAL TRANSDUCTION
细胞粘附在生物信号转导中的作用
- 批准号:
5210031 - 财政年份:
- 资助金额:
$ 7.28万 - 项目类别: